Skip to main content
letter
. 2022 Jan 14;84(5):e92–e93. doi: 10.1016/j.jinf.2022.01.015

Table 1.

The causal association of allergic disease with COVID-19.

Method nsnp Beta SE p val OR OR_lci95 OR_uci95
MR Egger 74 −0.211 0.097 0.033 0.810 0.669 0.979
Weighted median 74 −0.106 0.052 0.041 0.900 0.813 0.995
IVW 74 −0.089 0.034 0.009 0.915 0.856 0.978

COVID-19: corona virus disease 2019; IVW: Inverse variance weighted; nsnp: the number of single-nucleotide polymorphisms; Beta: the regression coefficient based on allergic disease raising effect allele; SE: standard error. p < 0.05 represents the causal association of the increased levels of allergic disease genetic IVs with COVID-19; OR: Odds ratio; OR_lci95: Lower limit of 95% confidence interval for OR; OR_uci95: Upper limit of 95% confidence interval for OR.